Can I Take My Wegovy a Day Earlier Than Scheduled?

Wegovy (semaglutide) is licensed as a once-weekly injection; the target gap between doses is seven days, every time.
A one-off day shift is permitted if the gap stays at four days or more, but regular early dosing is not supported by the product's clinical evidence.
The STEP 1 trial, which underpins Wegovy's UK licence, was conducted on a strict seven-day interval; results cannot be assumed to transfer to different schedules.
Any change to your injection schedule should be agreed with a GPhC-registered prescriber, not adjusted independently.

Taking Wegovy a day earlier than your usual injection day is generally not recommended. The licensed schedule is once weekly, with doses spaced as close to seven days apart as possible. Official guidance published on the NHS semaglutide medicines page confirms that if you need to shift your injection day, you can do so, but only once, and the gap between the two doses must be at least four days. Shifting by a single day every week, or routinely taking it early, falls outside the licensed use of this prescription-only medicine and should be discussed with your prescriber before you act on it.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

What the evidence and prescribing guidance actually say about shifting your Wegovy day

Why the seven-day interval exists in the first place

Semaglutide has a half-life of roughly one week. That pharmacological fact is precisely why it works as a once-weekly injection: the drug accumulates to a steady-state concentration in the body over several weeks, maintaining a consistent suppression of appetite between doses. The STEP 1 trial, published in the New England Journal of Medicine, enrolled participants on a fixed seven-day dosing schedule and recorded the average weight reduction of around 15% over 68 weeks on that basis. Those results are what support Wegovy's UK licence and NICE's recommendation. Varying the interval changes the concentration curve the trial was designed around. If you are wondering whether taking Wegovy a day early is something you can do safely, it helps to understand that taking the injection early week after week compresses that curve, while taking it late stretches it. Neither scenario has been studied in the same depth as the standard schedule.

None of this means a one-day variation will cause harm. But it does mean the evidence base for effectiveness was built on seven-day spacing, and no one can tell you with confidence what a persistent six-day interval does to long-term outcomes. That is a gap in the evidence worth acknowledging honestly.

When a one-off early injection is acceptable

Life is not always tidy. A planned holiday, a medical procedure, or a diary clash may mean your usual injection day genuinely does not work one week. The NHS guidance on semaglutide allows for a one-time shift, provided at least four days have passed since your previous dose. So if you normally inject on a Saturday and something unavoidable falls that day, injecting on the preceding Tuesday is within the four-day minimum, and you can then return to your usual day the following Saturday.

The key words there are "one-time" and "four days minimum." Routinely injecting six days after the previous dose, because it suits your week better, is a different matter. If a different day of the week suits your life more consistently, the right answer is to formally shift your injection day once, using the four-day rule as the bridge, and then hold the new day consistently. A question our prescribers hear regularly is whether people can just quietly move their day a little each week; the answer is that it is better to make a clean switch than to drift gradually.

The practical side: scheduling around everyday life

Most people settle on an injection day tied to something reliable: a Sunday evening routine, or a weekday morning before work. If your current day no longer fits, perhaps because of a shift pattern change or a new commitment that falls on that day, it is worth thinking about whether to move it permanently rather than nudging it earlier each week. Pick a new fixed day, use the four-day minimum gap to make the transition, then stay there.

Storage matters here too. Wegovy pens need to be kept refrigerated between 2°C and 8°C, and the room-temperature window before use is limited. If a schedule change means your pen sits out longer than planned while you decide what to do, check the Patient Information Leaflet for exact guidance on how long it can remain unrefrigerated before it should be discarded. Our FAQs cover storage questions that come up most often.

If you are considering whether Wegovy is the right treatment for your situation at all, including whether it is appropriate if you only want to lose around 10 pounds, the cost context for Wegovy in the UK is a useful place to start before a consultation. For a broader look at the semaglutide evidence and how the injection compares with other licensed options, the Wegovy treatment overview covers the full picture. Questions about BMI eligibility for Wegovy are also common at this stage.

Talk to your prescriber before changing anything

Wegovy is a prescription-only medicine, and the prescriber who signs off your treatment has visibility of your full clinical picture. A small scheduling question might feel like something you can resolve by searching online, and in part you can, but acting on general information without telling your prescriber means they are working from incomplete information at your next review. That matters especially if you are at a dose-increase stage, or if you have had any side effects that your prescriber needs to factor in.

If you are already on treatment through another provider and are thinking about switching, similar questions about semaglutide timing apply regardless of where your prescription originates. At nume, every repeat order goes through a clinical review before dispatch, which means there is a natural checkpoint to raise exactly this kind of question. If you are not yet on treatment and want to understand whether you are eligible, checking your eligibility is the first step.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions